Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04141683
Other study ID # RESERVE
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 10, 2019
Est. completion date December 2022

Study information

Verified date May 2021
Source Heart Center Leipzig - University Hospital
Contact Philipp Lurz, MD, PhD
Phone +49341865252022
Email philipp.lurz@medizin.uni-leipzig.de
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Aim of the study is to investigate the prognostic value of right ventricular contractile reserve in patients with functional tricuspid regurgitation undergoing tricuspid valve repair or replacement.


Description:

Chronic volume overload in patients with severe tricuspid regurgitation (TR) leads to right ventricular (RV) dilatation, fibrosis and eventually failure. RV dysfunction is an important determinant of mortality in patients undergoing tricuspid valve surgery. Aim of the current study is to investigate the prognostic utility of right ventricular contractile reserve in patients with severe TR undergoing surgical or interventional tricuspid valve repair or tricuspid valve replacement. RV contractile reserve will be assessed using semi-supine bicycle stress echocardiography. Echocardiographic parameters are prone to altered loading conditions, such as volume overload. Load independent RV contractility can only be measured using invasive pressure-volume-loop (PVL) analysis. Therefore RV PVL analysis will be done using conductance catheter in a subset of patients who undergo right heart catheterization for clinical evaluation of pulmonary hypertension. Aim of this sub study is the validation of non-invasively derived RV contractile reserve with load independent markers of intrinsic RV contractility.


Recruitment information / eligibility

Status Recruiting
Enrollment 108
Est. completion date December 2022
Est. primary completion date September 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Severe functional tricuspid regurgitation. - Planned surgical or interventional tricuspid valve repair or replacement. - Able to cycle on a semisupine tilting exercise table. - Informed consent. Exclusion Criteria: - Coronary artery disease with significant ischemia. - Unstable Angina. - Myocardial infarction <4 month prior to inclusion. - Concomitant valvular heart disease (aortic, mitral or pulmonary valve) > mild-moderate. - Constrictive pericarditis. - Malignant disease with a life expectancy < 12 months. - Pregnancy. - Insufficient image quality on echocardiography.

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Stress Echocardiography
Dynamic stress echocardiography using a cycle ergometer on a semi supine exercise table.
Pressure volume loop analysis
Pressure volume loop analysis unsing conductance catheter measurements during right heart catheterization.
Procedure:
Tricuspid valve repair or replacement
Tricuspid valve repair or replacement using a surgical or interventionale approach according to local heart team recommendation and patients' preference.

Locations

Country Name City State
Germany Heart Center Leipzig at Leipzig University Leipzig

Sponsors (1)

Lead Sponsor Collaborator
Heart Center Leipzig - University Hospital

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Death or heart failure hospitalization Death or heart failure hospitalization according to right ventricular contractile reserve. 6-12 month
Secondary Death Death according to right ventricular contractile reserve. 6-12 month
Secondary Cardiovascular Death Cardiovascular Death according to right ventricular contractile reserve. 6-12 month
Secondary Heart Failure Hospitalization Heart Failure Hospitalization according to right ventricular contractile reserve. 6-12 month
Secondary Intrinsic RV contractility Correlation of RV contractile reserve with the slope of invasively derived right ventricular end systolic elastance. Baseline
See also
  Status Clinical Trial Phase
Terminated NCT03632967 - Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System N/A
Recruiting NCT02721524 - Ring Versus Suture Annuloplasty For Functional Tricuspid Regurgitation In Rheumatic Mitral Valve Diseases N/A
Recruiting NCT05209919 - Echocardiographic Assessment and CLInical imPlication of Functional tricuSpid rEgurgitation in Heart Failure With Reduced or Preserved Ejection Fraction
Completed NCT05854095 - The Study for Evaluation of Acute Phase Safety and Efficacy of 'Pivot Bridge' to Short-term Treat FTR N/A
Completed NCT05648838 - Evaluation of Safety and Efficacy of Pivot Balloon to Monitoring Acute RV Failure and Reduction of FTR N/A
Completed NCT04078867 - Outcome of MC3 Ring Annuloplasty for Functional Tricuspid Regurgitation
Recruiting NCT04173091 - Risk Stratification in Severe Treatment-naive, Tricuspid Regurgitation
Completed NCT05836415 - Effectiveness and Durability Long-term Results of Tricuspid Annuloplasty With 3D Shaped Rings.
Recruiting NCT05920824 - Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation